Ireland
# |
Name |
Total Assets |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 11.39 B
|
Dec. 31, 2023 | USD 122.96 | -0.16% |
|
Ireland |
|
2 |
USD 2.14 B
|
Dec. 31, 2023 | USD 28.50 | 0.53% |
|
Ireland |
|
3 |
USD 696.38 M
|
Dec. 31, 2023 | USD 12.67 | -3.50% |
|
Ireland |
|
4 |
USD 226.30 M
|
Dec. 31, 2023 | USD 8.19 | -1.92% |
|
Ireland |
|
5 |
USD 164.70 M
|
Dec. 31, 2023 | USD 8.05 | 2.94% |
|
Ireland |
|
6 |
USD 48.66 M
|
Dec. 31, 2023 | USD 4.34 | 1.19% |
|
Ireland |
|
7 |
USD 26.26 M
|
Dec. 31, 2023 | USD 1.60 | -2.44% |
|
Ireland |
The Biotechnology company in Ireland with the highest Total Assets is Jazz Pharmaceuticals plc (NasdaqGS: JAZZ) at USD 11.39 B.
The Biotechnology company in Ireland with the lowest Total Assets is Iterum Therapeutics plc (NasdaqCM: ITRM) at USD 26.26 M.
The top 10 Biotechnology companies in Ireland by Total Assets are Jazz Pharmaceuticals plc, Alkermes plc, Prothena Corporation plc, GH Research PLC, Avadel Pharmaceuticals plc, kneat.com, inc. and Iterum Therapeutics plc.
The bottom 10 Biotechnology companies in Ireland by Total Assets are Iterum Therapeutics plc, kneat.com, inc., Avadel Pharmaceuticals plc, GH Research PLC, Prothena Corporation plc, Alkermes plc and Jazz Pharmaceuticals plc.